Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Magnetic resonance imaging (MRI) assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomized, double-blind, placebo-controlled Phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8, and 16.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations
Original languageEnglish
JournalScandinavian Journal of Rheumatology
Issue numberSuppl. 127
Pages (from-to)14
Number of pages1
Publication statusPublished - 2014

ID: 44698635